Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer

Gynecologic Oncology

Volumn 52, Issue 3, 1994, Pages 386-391

  Gadducci, Angiolo ^a   Ferdeghini, Marco ^a   Malagnino, Gabriella ^a   Proniera, Concetta ^a   Fanucchi, Antonio ^a   Annicchiarico, Carmela ^a   Bianchi, Romano ^a   Fioretti, Piero ^a   Facchini, Virgilio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028211730     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1994.1066     Document Type: Article

References (38)

1. Duchs, D. S., Bowers, D. S., Woolf, J. H., and Nichol, C. A., Biopterin cofactor biosynthesis'. GTP-cycIohydrolase, neopterin and biopterin in tissue and body fluid of mammalian species, Life Sci.35 1895-1901 (1984).
2. Huber, C., Batchelor, J. R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J., and Watcher, H. Immune response-associated production of neopterin: Release from macrophages primarily under control of interferony J. Exp. Med. 160, 310-316 (1984).
3. Werner, E. R., Bichler, A., Daxenbichler, G., Fuchs, D, Fuith, L. C., Hausen, A., Hetzel, H., Reibnegger, G., and Watcher, H. Determination of neopterin in serum and urine, Clin. Chem. 33, 62-66 (1987).
4. Aulitzky, W., Frick, J., Fuchs, D., Hausen, A., Reibnegger, G., and Watchter, H. Significance of urinary neopterin in patients with malignant tumors of the genitourinary tract, Cancer 55, 1052-1055. (1985).
5. Schwedes, U., Teuber, J., Schmidt, R., and Usadel, K. H., Neop-terin as a marker for the activity of autoimmune thyroid diseases, Acta Endocrinol. 3, 51-52 (1986).
6. Reibnegger, G. J., Bichler, A. H., Dapunt, O., Fuchs, D. N., Fuith, L. C., Hausen, A., Hetzel, H. M., Lutz, H., Werner, E. R., and Wachter, H. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix, Cancer Res. 46, 950-955. (1986).
7. Reibnegger, G., Hetzel, H., Fuchs, D., Fuith, L. C., Hausen, A., Werner, E. R., and Wachter, H. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer, Cancer Res. 47, 4977-4981 (1987).
8. Fuchs, D. N., Fuith, L. C., Hausen, A., Hetzel, H., Reibnegger, G. J., Werner, E. R., and Wachter, H. Preactivated T cells in cancer patients with poor prognosis, Cancer Detect. Prev. 12, 97-103 (1988).
9. Reibnegger, G., Auhuber, I., Fuchs, D., Hausen, A., Judmaier, G., Prior, C., Werner, E. R., and Wachter, H. Urinary neopterin levels in acute viral hepatitis, Hepatology 8, 771-774 (1988).
10. Fuith, L. C-, Fuchs, D., Hausen, A., Hetzel, H., Reibnegger, G., Werner, E. R., and Wachter, H. Urinary neopterin excretion in patients with uterine sarcomas, Cancer 65, 1228-1231 (1990).
11. Leohirun, L., Thuvasethakul, P., Sumethkul, V., Pholcharoen, T., and Boonpucknavig, V. Urinary neopterin in patients with systemic lupus erythematosus, Clin. Chem. 37, 47-50 (1991).
12. Smith, K. A., Interleukin 2, Annu. Rev. Immunol. 2, 319-333 (1984).
13. Malkovsky, M, and Sondel, P. M., Interleukin 2 and its receptor: structure, function ad therapeutic potential, Blood. Rev. 1, 254-266 (1987).
14. Smith, K. A., The interleukin 2 receptor, Adv. Immunol. 42, 165- 179 (1988).
15. Rubin, L. A., Kurman, C. C., Fritz, M. E., Biddison, W. E., Boutin, B., Yarchoan, R., and Nelson, D. L., Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro, J. Immunol., 135, 3172-3177 (1985).
16. Rubin, L. A., Jay, G., and Nelson, D. L., The released interleukin-2 receptor binds interleukin-2 efficiently, J. Immunol. 137, 3841-3845 (1986).
17. Harrington, D. S., Patil, K., Lai, P. K., Yasuda, N. N., Armitage, J. O., Ip, S. H., Weisenburger, D. D., Linder, J., and Purtilo, D T. Soluble interleukin 2 receptors in patients with malignant lymphoma, Arch. Pathol. Lab. Med. 112, 597-601 (1988).
18. Semenzato, G., Bambara, L. M., Biasi, D., Frigo, A., Vinante, F., Zuppini, B., Trentin, L., Feruglio, C., Chilosi, M., and Pizzolo, F. Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis, J. Clin. Immunol. 8, 447-452 (1988).
19. Lai, K. N., Leung, J., Lai, F. M., and Tam, J. S., Early T lymphocyte activation in IgA nephropathy: Soluble interleukin 2 receptor (IL2R) production, cellular IL2R expression and interleukin 2 release, J. Clin. Immunol. 9, 485-492 (1989).
20. Rovelli, F., Lissoni, P., Crispino, S., Barni, S., Fumagalli, G., Paolorossi, F., and Tancini, G. Increased level of soluble interleukin-2 receptor in advanced solid tumors: A preliminary study, Tumori 74, 633-637 (1988).
21. Chilosi, M., Semenzato, G., Vinante, F., Menestrina, F., Piazzola, E., Focchiatti, V., Sabbioni, R., Zanotti, R., and Pizzoio, G. Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas: Relationship with clinical histologic and phenotypic features, Am. J. Clin. Pathol. 92, 186-191 (1989).
22. Lissoni, P., Barni, S., Rovelli, F, Viviani, S., Maestroni, G. J., Conti, A., and Tancini, G. The biological significance of soluble interleukin-2 receptors in solid tumors, Eur. J. Cancer 26, 33-36 (1990).
23. Lai, K. N., Ho, S., Leung, J. C. K., and Tsao, S. Y., Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma, Cancer 67, 2180-2185 (1991).
24. Poulakis, N., Sarandakou, A., Rizos, D., Phocas, I., Kontozoglou, T., and Polyzogopoulos, D. Soluble interleukin-2 receptors and other markers in primary lung cancer, Cancer 68, 1045-1049 (1991).
25. Bichler, A., Fuchs, D., Hausen, A., Hetzel, H., Reibnegger, G., and Wachter, H. Measurement of urinary neopterin in normal pregnant and nonpregnant women and in women with benign and malignant genital tract neoplasms, Arch. Gynecol. 223, 121-130 (1983).
26. Hetzel, H., Bichler, A., Fuchs, D., Hausen, A., Reibnegger, G., and Wachter, H. Signicance of urinary neopterine in gynecological oncology: Follow-up of patients with ovarian cancer, Cancer Detect. Prev. 6, 263-266 (1983).
27. Tisi, E., Lissoni, P., Angeli, M., Arrigoni, C., Corno, E., Cassina, E., Ballabio, D., Benenti, C., Barni, S., and Tancini, G. Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma, Cancer 69, 2458-2462 (1992).
28. Youden, W. J., Index for rating diagnostic tests, Cancer 3, 32-35 (1950).
29. Gadducci, A., Ferdeghini, M., Ceccarini, T., Prontera, C., Facchini, V., Bianchi, R., and Fioretti, P. A comparative evaluation of the ability of serum CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma, Eur. J. Gynaecol. Oncol. 11, 127-133 (1990).
30. Fioretti, P., Gadducci, A., Ferdeghini, M., Prontera, C., Mal-agnino, G., Facchini, V., Mariani, G., and Bianchi, R. The concomitant determination of different serum tumor markers in epithelial ovarian cancer: Relevance for monitoring the response to chemotherapy and follow-up patients, Gynecol. Oncol. 44, 155- 160 (1992).
31. Mavier, P., and Edgington, T. S., Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism, J. Immunol. 132, 1980-1986 (1984).
32. Bartel, U., Rabe, H., and Schulz-Pinkus, M. Initial experiences with the determination of neopterin in the urine of females with genital and breast tumors, Zentralbl. Gynaekol. 109, 1226-1232 (1987).
33. Von Broen, B., and Kavungu, P. Value of neopterin as an oncologic laboratory parameter-observations in gynecologic tumors, Gesamte Inn. Med. 45, 223-225 (1990).
34. Barton, D. P., Blanchard, D. K., Nicosia, S. V., Canavagh, D., and Djeu, J. H., Soluble interleukin-2 receptor alpha (sIL-2R alpha) levels and cell surface IL-2R alpha expression in peripheral blood and ascites of patients with ovarian carcinoma, Proc. Annu. Meet. Arn. Assoc. Cancer Res. 343, A1384 (1992).
35. Jacobs, I., and Bast, R. C., Jr. The CA125 tumor-associated antigen: a review of the literature, Hum. Reprod. 4, 1-12 (1989).
36. Soper, J. T., Hunter, V. J, Daly, L., Tanner, M., Creasman, W. T., and Bast, R. C., Jr. Preoperative serum tumor-associated antigen levels in women with pelvic masses, Obstet. Gynecol. 75, 249-254 (1990).
37. Gadducci, A., Ferdeghini, M., Prontera, C., Moretti, L., Mariani, G, Bianchi, R, and Fioretti, P. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis, Gynecol. Oncol. 44, 147-154 (1992).
38. Munzarova, M., and Kovarik, J. Is cancer a macrophage-mediated autoaggressive disease? Lancet 1, 952-954 (1987).